Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-10-11

Clinical Trial Update: Bubiket Study: Ultrasound Guided Fascia Iliaca Nerve Block With Bupivacaine and Adjuvant Ketamine vs. Bupivacaine Alone [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ultrasound-guided fascia iliaca nerve block with bupivacaine plus ketamine adjuvant versus bupivacaine alone was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Ketamine (ketamine)

Snippet

Sponsor: Antonios Likourezos | Conditions: Pain, Musculoskeletal | Phase 4 | Status: WITHDRAWN